| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 72,365 | 69,585 | 68,585 | 72,921 | | Cost of Revenue | 4,112 | 3,219 | 2,955 | 1,668 | | | Gross Profit | 68,253 | 66,366 | 65,630 | 71,253 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,284 | 5,231 | 4,820 | 4,630 | | Non Recurring | 11,766 | 1,282 | 112 | 5,439 | | Others | 19,689 | 18,635 | 18,389 | 17,596 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,918) | 41,218 | 42,309 | 43,588 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (5,168) | 41,218 | 42,309 | 43,588 | | Interest Expense | 15,949 | 10,707 | 10,776 | 11,220 | | Income Before Tax | (21,117) | 30,511 | 31,533 | 32,368 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (21,117) | 30,511 | 31,533 | 32,368 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,565 | 30,511 | 31,533 | 32,368 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,565 | $30,511 | $31,533 | $32,368 |
|
0.11% Nasdaq 0.00%
Income Statement
